Phosphorylation of hepatocyte growth factor receptor and epidermal growth factor receptor of human hepatocytes can be maintained in a (3D) collagen sandwich culture system

被引:14
|
作者
Engl, T
Boost, KA
Leckel, K
Beecken, WD
Jonas, D
Oppermann, E
Auth, MKH
Schaudt, A
Bechstein, WO
Blaheta, RA
机构
[1] Goethe Univ Frankfurt, Univ Klin, Klin Urol & Kinderurol, Zentrum Chirurg, D-60590 Frankfurt, Germany
[2] Goethe Univ Frankfurt, Klin Allgemein & Gefasschirurg, Zentrum Chirurg, Frankfurt, Germany
[3] Univ Klinikum, Zentrum Kinderheilkunde, Essen, Germany
关键词
human hepatocytes; drug toxicity; cell architecture;
D O I
10.1016/j.tiv.2004.01.010
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
In vitro culture models that employ human liver cells could be potent tools for predictive studies on drug toxicity and metabolism in the pharmaceutical industry. However, an adequate receptor responsiveness is necessary to allow intracellular signalling and metabolic activity. We tested the ability of three-dimensionally arranged human hepatocytes to respond to the growth factors hepatocyte growth factor (HGF) or epidermal growth factor (EGF). Isolated adult human hepatocytes were cultivated within a three-dimensional collagen gel (sandwich) or on a two-dimensional collagen matrix. Cells were treated with HGF or EGF and expression and phosphorylative activity of HGF receptors (HGFr, c-met) or EGF receptors (EGFr) were measured by flow cytometry and Western blot. Increasing HGFr and EGFr levels were detected in hepatocytes growing two-dimensionally. However, both receptors were not activated in presence of growth factors. In contrast, when hepatocytes were plated within a three-dimensional matrix, HGFr and EGFr levels remained constantly low. However, both receptors became strongly phosphorylated by soluble HGF or EGF. We conclude that cultivation of human hepatocytes in a three-dimensionally arranged in vitro system allows the maintenance of specific functional activities. The necessity of cell dimensionality for HGFr and EGFr function should be considered when an adequate in vitro system has to be introduced for drug testing. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:527 / 532
页数:6
相关论文
共 50 条
  • [1] Epidermal growth factor- and hepatocyte growth factor-receptor activity in serum-free cultures of human hepatocytes
    Runge, DM
    Runge, D
    Dorko, K
    Pisarov, LA
    Leckel, K
    Kostrubsky, VE
    Thomas, D
    Strom, SC
    Michalopoulos, GK
    JOURNAL OF HEPATOLOGY, 1999, 30 (02) : 265 - 274
  • [2] Epidermal growth factor receptor and tyrosine phosphorylation of estrogen receptor
    Diana C. Márquez
    Julie Lee
    Theodore Lin
    Richard J. Pietras
    Endocrine, 2001, 16 : 73 - 81
  • [3] Epidermal growth factor receptor and tyrosine phosphorylation of estrogen receptor
    Márquez, DC
    Lee, J
    Lin, T
    Pietras, RJ
    ENDOCRINE, 2001, 16 (02) : 73 - 81
  • [4] Human Epidermal Growth Factor Receptor 2/Human Epidermal Growth Factor Receptor 3 PET Imaging Challenges and Opportunities
    Ducharme, Maxwell
    Mansur, Ameer
    Sligh, Luke
    Ulaner, Gary A.
    Lapi, Suzanne E.
    Sorace, Anna G.
    PET CLINICS, 2023, 18 (04) : 543 - 555
  • [5] 3D Trafficking of Epidermal Growth Factor Receptor in Live Cells
    Mendez, Marco A. Alfonzo
    Viswasrao, Harshad
    Shroff, Hari
    Taraska, Justin W.
    BIOPHYSICAL JOURNAL, 2019, 116 (03) : 93A - 93A
  • [6] QSAR and 3D QSAR of inhibitors of the epidermal growth factor receptor
    Pinto-Bazurco, M
    Tsakovska, I
    Pajeva, I
    INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY, 2006, 106 (06) : 1432 - 1444
  • [7] Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor
    Reznik, Thomas E.
    Sang, Yingying
    Ma, Yongxian
    Abounader, Roger
    Rosen, Eliot M.
    Xia, Shuli
    Laterra, John
    MOLECULAR CANCER RESEARCH, 2008, 6 (01) : 139 - 150
  • [8] PHOSPHORYLATION OF CYTOSKELETAL PROTEINS IN RAT HEPATOCYTES STIMULATED WITH HEPATOCYTE GROWTH-FACTOR OR EPIDERMAL GROWTH-FACTOR
    STOLZ, DB
    MICHALOPOULOS, GK
    FASEB JOURNAL, 1993, 7 (07): : A1238 - A1238
  • [9] Clinical Potential of Human Epidermal Growth Factor Receptor 2 and Human Epidermal Growth Factor Receptor 3 Imaging in Breast Cancer
    Henry, Kelly E.
    Ulaner, Gary A.
    Lewis, Jason S.
    PET CLINICS, 2018, 13 (03) : 423 - +
  • [10] Targeting human epidermal growth factor receptor 2: It is time to kill kinase death human epidermal growth factor receptor 3
    Menendez, Javier A.
    Lupu, Ruth
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (17) : 2496 - 2498